Administrative and Support and Waste Management and Remediation Services Ptix

Protagenic Therapeutics Inc

PTIX 4 | $1.37 5.59% 4.3K

(0.0% 1d) (-9.8% 1m) (-28.9% 1y) (0.0% 2d) (-4.4% 3d) (-7.7% 7d) (226.24% volume)
Earnings Calendar:
Market Cap: $ 6,076,131
https://protagenic.com
Sec Filling | Patents | n/a employees

Protagenic Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of novel and naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Protagenic Therapeutics offers its services in the United States.

msa hormone treatment

add to watch list Paper trade email alert is off

Press-releases

Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders
Published: 2024-02-13 (Crawled : 14:30) - biospace.com/
PTIX 4 | $1.37 5.59% 4.3K

Administrative and Support and ...

| 34.49% | O: 4.25% H: 20.0% C: -3.0%
first disorders treatment therapeutics potential milestone

Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update
Published: 2021-11-16 (Crawled : 15:00) - globenewswire.com
PTIX 4 | $1.37 5.59% 4.3K

Administrative and Support and ...

| -35.18% | O: -1.01% H: 0.25% C: -1.52%
results therapeutics

Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update
Published: 2021-08-17 (Crawled : 12:00) - globenewswire.com
PTIX 4 | $1.37 5.59% 4.3K

Administrative and Support and ...

| -26.29% | O: -4.0% H: 10.12% C: 7.14%
results

Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial
Published: 2021-07-23 (Crawled : 21:00) - globenewswire.com
PTIX 4 | $1.37 5.59% 4.3K

Administrative and Support and ...

| Email alert Add to watchlist
trial enroll

Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 AM ET
Published: 2021-07-06 (Crawled : 11:00) - globenewswire.com
PTIX 4 | $1.37 5.59% 4.3K

Administrative and Support and ...

| -51.14% | O: 4.55% H: 0.0% C: -3.99%

Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th
Published: 2021-06-16 (Crawled : 14:00) - globenewswire.com
PTIX 4 | $1.37 5.59% 4.3K

Administrative and Support and ...

| -57.28% | O: -7.62% H: 23.3% C: 11.47%
conference

Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to Nasdaq
Published: 2021-04-29 (Crawled : 20:00) - globenewswire.com
PTIX 4 | $1.37 5.59% 4.3K

Administrative and Support and ...

| -45.34% | O: -0.85% H: 0.85% C: -3.42%
offering nasdaq

Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public Offering
Published: 2021-04-27 (Crawled : 01:00) - globenewswire.com
PTIX 4 | $1.37 5.59% 4.3K

Administrative and Support and ...

| -65.23% | O: -16.77% H: 0.0% C: -27.45%
offering nasdaq

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001493152-24-012598	4	2024-04-02	2024-03-25	Buy	A	21250	21250
0001493152-24-012073	4	2024-03-30	2024-03-25	Buy	A	75000	75000
0001493152-24-012070	4	2024-03-30	2024-03-25	Buy	A	22500	22500
0001493152-24-012071	4	2024-03-30	2024-03-25	Buy	A	75000	75000
0001493152-24-012068	4	2024-03-30	2024-03-25	Buy	A	250000	250000